Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Patent CN1754963A details a solvent-free enzymatic route for pyroglutamic acid esters, offering high purity and cost-effective manufacturing for personal care suppliers.
Patent CN112795603B reveals a high-efficiency IRED method for chiral pyrrolidines, offering superior purity and green manufacturing advantages.
Patent CN102277320B reveals enzymatic IDA synthesis reducing waste. Discover cost-effective, high-purity agrochemical intermediate solutions for glyphosate production.
Patent CN101701243B details a high-efficiency biocatalytic route for R-mandelic acid using Alcaligenes faecalis, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN109749968A details Bacillus velezensis strain for efficient (R)-1,3-butanediol synthesis. Delivers high purity, mild conditions, and supply chain stability for pharmaceutical manufacturing.
Novel Acinetobacter strain enables high-concentration biocatalysis for chiral acid production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN115976130A reveals a novel enzymatic route for Rimegepant intermediate VI, achieving 90.1% yield and superior impurity control for reliable pharmaceutical supply chains.
Patent CN111349677B details high-purity steroid intermediate synthesis using recombinant enzymes for cost-effective pharmaceutical manufacturing supply chains and reduced environmental impact.
Novel enzymatic method for L-2-aminobutyric acid production. Low cost, high yield, scalable process for pharmaceutical intermediates and supply chain optimization.
Patent CN105779555B details a one-step microbial conversion for prednisolone intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Patent CN102465159A reveals a green microbial route for Eslicarbazepine. Discover cost-effective, high-purity manufacturing solutions for API intermediates.
Patent CN104328152A details high-yield biocatalytic synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN104313073A reveals high-yield biocatalytic route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Patent CN104263774A reveals high-yield yeast catalysis. Offers supply chain reliability and cost reduction in chiral intermediate manufacturing for global pharma.
High-purity chiral intermediate via black mold catalysis. Scalable production with significant cost and supply chain advantages for global buyers.
Patent CN104313078A reveals high-yield biocatalytic route for chiral thiazole ethanol ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN112795606A reveals a novel PNP/NRK enzymatic route for NMN. Achieve superior conversion rates and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN108823179A reveals high-efficiency transaminase mutant for R-3-aminobutanol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.